TerminatedEUCTR 2021-000592-36
Calcitonin Gene-Related Peptide Receptor Antagonists for Prevention of Acute Mountain Sickness
This historical record does not confirm current site availability.
Historical research recordGermanyEating disorders
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Germany
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Universitätsklinikum Essen
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2021-000592-36
- Official title
Show the full official title
Calcitonin Gene-Related Peptide Receptor Antagonists for Prevention of Acute Mountain Sickness
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Germany
Registry details
Historical country statuses
- Germany — Prematurely Ended
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Universitätsklinikum Essen.
Is this study still recruiting?
The historical registry lists this study as terminated.
